Seroepidemiology of Human T Cell Lymphotropic Virus in the Republic of Panama

William C. Reeves Gorgas Memorial Laboratory, Environmental Epidemiology Branch, National Cancer Institute, Laboratory of Tumor Cell Biology, National Cancer Institute, Panama, Republic of Panama

Search for other papers by William C. Reeves in
Current site
Google Scholar
PubMed
Close
,
Paul H. Levine Gorgas Memorial Laboratory, Environmental Epidemiology Branch, National Cancer Institute, Laboratory of Tumor Cell Biology, National Cancer Institute, Panama, Republic of Panama

Search for other papers by Paul H. Levine in
Current site
Google Scholar
PubMed
Close
,
Marina Cuevas Gorgas Memorial Laboratory, Environmental Epidemiology Branch, National Cancer Institute, Laboratory of Tumor Cell Biology, National Cancer Institute, Panama, Republic of Panama

Search for other papers by Marina Cuevas in
Current site
Google Scholar
PubMed
Close
,
Evelia Quiroz Gorgas Memorial Laboratory, Environmental Epidemiology Branch, National Cancer Institute, Laboratory of Tumor Cell Biology, National Cancer Institute, Panama, Republic of Panama

Search for other papers by Evelia Quiroz in
Current site
Google Scholar
PubMed
Close
,
Elizabeth Maloney Gorgas Memorial Laboratory, Environmental Epidemiology Branch, National Cancer Institute, Laboratory of Tumor Cell Biology, National Cancer Institute, Panama, Republic of Panama

Search for other papers by Elizabeth Maloney in
Current site
Google Scholar
PubMed
Close
, and
W. Carl Saxinger Gorgas Memorial Laboratory, Environmental Epidemiology Branch, National Cancer Institute, Laboratory of Tumor Cell Biology, National Cancer Institute, Panama, Republic of Panama

Search for other papers by W. Carl Saxinger in
Current site
Google Scholar
PubMed
Close
Restricted access

The human T-lymphotropic virus (HTLV) and associated diseases, adult T cell leukemia and spastic paraparesis, appear to be endemic in southwestern Japan and the Caribbean. This cross-sectional population-based study was conducted to describe the seroepidemiology of HTLV in the Republic of Panama. HTLV antibody was measured by first generation and commercial ELISA tests and confirmed by competitive binding ELISA, a radioimmunoassay for anti-p 24, and Western blot. Of 3,231 subjects ≥15 years of age, 135 (4.2%) had antibody detected in ELISA screening tests, but because only 20% were confirmed positive, HTLV seroprevalence varied from 0.2–2% throughout the Republic. Infection with HTLV clustered in Guaymi Indians living in Bocas del Toro province (9.9% prevalence rate). With the exception of Guaymi Indians, no major geographic, urban/rural, male/female or racial differences in antibody prevalence were observed; specifically, HTLV infection rates were not elevated in black Panamanians. Clustering of infection in an isolated Amerind population must be further investigated. The small proportion of screen-positive sera which confirmed positive illustrates the importance of strict uniform criteria for seropositivity.

Author Notes

Save